Single-Blind, Multicenter, Placebo Controlled, Parallel Study to Assess the Safety and Efficacy of Intralesional Interferon α-2b for Minimally Invasive Treatment for Peyronie’s Disease
Journal of Urology | June 5, 2006 | Volume: 176 | Issue: 1 | Pages: 394-398
10.1016/s0022-5347(06)00517-9
| PMID 16753449